Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy

February 19, 2026 updated by: Loma Linda University

Post-operative Outcomes of Tonsillectomy With Lateral Pharyngoplasty Versus Tonsillectomy Alone in Children: a Randomized Controlled Trial

The goal of this treatment study is to determine if doing lateral pharyngoplasty with tonsillectomy is better for children than doing tonsillectomy alone. The main questions it aims to answer are:

  • Do children experience less pain after surgery when lateral pharyngoplasty is performed with tonsillectomy compared to tonsillectomy alone?
  • Do children eat/drink better when lateral pharyngoplasty is performed with tonsillectomy compared to tonsillectomy alone?
  • Is there a lower risk of bleeding after tonsillectomy when lateral pharyngoplasty is performed? Researchers will compare children undergoing tonsillectomy and lateral pharyngoplasty with children undergoing tonsillectomy alone to see if the participants experience less pain, better oral intake, and less bleeding complications after surgery. Parents of participants will be asked to record pain scores and pain medications given, approximate amounts of daily oral intake, and any complications after surgery.

Study Overview

Detailed Description

This is a randomized controlled trial to elucidate the benefits of performing lateral pharyngoplasty with tonsillectomy and encourage its use as a standard of care procedure. Participants will be randomized to receive either tonsillectomy +/- adenoidectomy or tonsillectomy +/- adenoidectomy with lateral pharyngoplasty (research intervention), with lateral pharyngoplasty referring to the placement two figure-of-8 sutures with 3-0 vicryl to reapproximate the anterior and posterior tonsillar pillars on each side. The investigators' hypothesis is that participants undergoing lateral pharyngoplasty will experience less pain, lower post-tonsillectomy hemorrhage rate, and a faster return to normal oral intake than participants undergoing tonsillectomy alone.

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ethan Frank, MD
  • Phone Number: (909) 558-8558
  • Email: efrank@llu.edu

Study Locations

    • California
      • Murrieta, California, United States, 92563
        • Not yet recruiting
        • Loma Linda University Professional Building - Murrieta
        • Contact:
          • Tsungju O-Lee, MD
          • Phone Number: 951-290-4000
          • Email: tolee@llu.edu
        • Sub-Investigator:
          • Vikrum Thimmappa, MD
        • Principal Investigator:
          • Tsungju O-Lee, MD
      • Riverside, California, United States, 92506
        • Recruiting
        • Loma Linda University ENT/Head & Neck Surgery
        • Sub-Investigator:
          • Vikrum Thimmappa, MD
        • Principal Investigator:
          • Tsungju O-Lee, MD
        • Contact:
          • Tsungju O-Lee, MD
          • Phone Number: 909-558-2824
          • Email: tolee@llu.edu
        • Contact:
      • San Bernardino, California, United States, 92408
        • Not yet recruiting
        • Pediatric Ear, Nose, and Throat Surgery and Audiology
        • Sub-Investigator:
          • Vikrum Thimmappa, MD
        • Principal Investigator:
          • Tsungju O-Lee, MD
        • Contact:
          • Tsungju O-Lee, MD
          • Phone Number: 909-558-2824
          • Email: tolee@llu.edu
        • Contact:
      • San Bernardino, California, United States, 92410
        • Not yet recruiting
        • SAC Health - ENT Clinic
        • Contact:
        • Principal Investigator:
          • Vikrum Thimmappa, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants ages 3-17 years of age undergoing tonsillectomy +/- adenoidectomy at Loma Linda University Health

Exclusion Criteria:

  • Subjects with congenital syndromes and/or developmental delay
  • Subjects with cancer
  • Subjects with gastrostomy tube use or dependence
  • Subjects undergoing intracapsular tonsillectomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Tonsillectomy +/- adenoidectomy
Participants will undergo extracapsular tonsillectomy +/- adenoidectomy.
Extracapsular tonsillectomy
Experimental: Tonsillectomy +/- adenoidectomy with lateral pharyngoplasty
Participants will undergo extracapsular tonsillectomy +/- adenoidectomy and lateral pharyngoplasty.
Extracapsular tonsillectomy
Two figure-of-8 sutures using 3-0 vicryl are used to approximate the anterior and posterior tonsillar pillars and reconstruct the continuous mucosal covering of the lateral pharyngeal walls.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of post-operative pain
Time Frame: Change between baseline (immediately post-op) through 6 weeks after surgery
Will use the Wong-Baker FACES pain scale, which shows a series of faces ranging from a happy face at 0 (representing no pain) to a crying face at 10 (representing the worst pain imaginable). Parent/caregiver will document the pain score and pain medication administrations/duration of use.
Change between baseline (immediately post-op) through 6 weeks after surgery
Number of participants with post-tonsillectomy hemorrhage requiring surgical intervention
Time Frame: Change between baseline (immediately post-op) through 6 weeks after surgery
Count of subjects who undergo control of post-tonsillectomy hemorrhage in the operating room
Change between baseline (immediately post-op) through 6 weeks after surgery
Number of participants with post-tonsillectomy hemorrhage not requiring surgical intervention
Time Frame: Change between baseline (immediately post-op) through 6 weeks after surgery
Count of subject/caregiver reports or presentations to a healthcare facility due to a post-tonsillectomy hemorrhage event that does not require control of hemorrhage in the operating room
Change between baseline (immediately post-op) through 6 weeks after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative duration (in days) to normal oral intake
Time Frame: Change between baseline (immediately post-op) through 6 weeks after surgery
Parent/caregiver's will estimate the participant's daily soft diet oral intake as a percentage of perceived baseline/normal
Change between baseline (immediately post-op) through 6 weeks after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants requiring intravenous fluid administration for dehydration
Time Frame: Change between baseline (immediately post-op) through 6 weeks after surgery
Presentation to healthcare facility due to lack of/perceived inadequate oral intake or decreased urination requiring intravenous fluid administration
Change between baseline (immediately post-op) through 6 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tsungju O-Lee, MD, Loma Linda University Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 17, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

October 7, 2022

First Submitted That Met QC Criteria

October 7, 2022

First Posted (Actual)

October 12, 2022

Study Record Updates

Last Update Posted (Actual)

February 23, 2026

Last Update Submitted That Met QC Criteria

February 19, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Apnea, Obstructive

Clinical Trials on Tonsillectomy

Subscribe